AI
PRTA icon

Analytic Investors’s Prothena Corp PRTA Stock Holding History

Analytic Investors’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,303
Closed -$480K – 651
2014
Q2 		$480K Sell
21,303
-3,175
-13% -$79.4K 0.01% 417
2014
Q1 		$938K Buy
+24,478
New +$789K 0.01% 362

Other funds holding PRTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Analytic Investors's PRTA Position: Q3 2014 in Review

Analytic Investors sold out of Prothena Corp (PRTA) in Q3 2014, closing a stake of 21,303 shares — an estimated $480K sold.

Analytic Investors first reported a position in PRTA in Q1 2014 and held it in 2 quarters. The position peaked at $938K in Q1 2014. 127 funds tracked by Wall St. Rank hold PRTA as of Q3 2014.

  • Analytic Investors reported no remaining Prothena Corp position as of Q3 2014 after selling out during the quarter.
  • Analytic Investors sold 21,303 Prothena Corp shares in Q3 2014, an estimated $480K.
  • Analytic Investors first reported a position in Prothena Corp in Q1 2014 and held it in 2 quarters.
  • Analytic Investors's Prothena Corp position peaked at $938K in Q1 2014.
  • 127 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2014.

Based on Analytic Investors's 13F filing for Q3 2014, filed 7 Nov 2014.